Clinical & Prescribing

Annual Flu Programme

Bookmark links to national guidance and any locally published LMC guidance/advice relating to annual flu programmes.

Bariatric Surgery

Advice relating to referral processes, follow up and surgeries in the UK and abroad

Benzodiazepines

Guidance on how to manage requests for benzodiazepines for travel and procedures, including a template policy and letter

Dental Presentations

This guidance aims to clarify responsibilities, outline good practice, and support GPs in managing dental-related presentations safely and appropriately.

Gender Identity

Guidance relating to patient records, confidentiality, prescribing, monitoring and health screening responsibilities

Inclisiran (Leqvio®) prescribing

Inclisiran (Leqvio®) prescribing remains a topic of ongoing concern among practices. This advice serves as a key reminder about formulary inclusion vs GP obligations.

Medicines Optimisation

Supporting dispensing practices to navigate the implications of medicines optimisation requirements on dispensary businesses

Mental Health Services Survey

A survey undertaken in Summer 2025 by Cambs LMC, of Local General Practice experience of local mental health services.

Non-compliance with monitoring

A typical process to assist practices with the management of patients who are non-compliant with medical monitoring

PSA Monitoring

Guidance and templates to support local General Practice considering safely stopping provision of non-commissioned PSA monitoring.

Shared Care

Key considerations for General Practice when faced with Shared Care requests

Travel Vaccinations

Guidance on NHS and non-NHS travel vaccinations and a sample policy that practices could adopt

Weight Loss Medication

Guidance to support practices when asked to undertake a review of patients who have been prescribed treatments by private providers

Weight Management Medication in Primary Care

From 23 June 2025, Tirzepatide must be implemented in primary care.